Salesforce (CRM) Stock Forecast & Price Target

$187.05 +1.57 (+0.85%)

Closing price 05/5/2026 03:59 PM Eastern

Extended Trading

$186.12 -0.93 (-0.50%)

As of 05/5/2026 07:59 PM Eastern

Compare

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 39 Analyst Ratings

Sell
1

Hold
11

Buy
27

Based on 39 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 39 analysts, 1 has given a sell rating, 11 have given a hold rating, 26 have given a buy rating, and 1 has given a strong buy rating for CRM.

Consensus Price Target

$279.18
49.25% Upside

According to the 39 analysts' twelve-month price targets for Salesforce, the average price target is $279.18. The highest price target for CRM is $430.00, while the lowest price target for CRM is $194.00. The average price target represents a forecasted upside of 49.25% from the current price of $187.05.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRM Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	4 Strong Buy rating(s)
Buy	26 Buy rating(s)	26 Buy rating(s)	28 Buy rating(s)	32 Buy rating(s)
Hold	11 Hold rating(s)	11 Hold rating(s)	12 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$279.18	$280.21	$320.61	$350.56
Forecasted Upside	49.25% Upside	51.37% Upside	68.99% Upside	28.11% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.69	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	49.25% Upside	156.93% Upside	14.74% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
4/17/2026	BTIG Research 2 of 5 stars	Allan Verkhovski Not Rated	Reiterated Rating	Buy	$255.00	+40.59%
4/14/2026	Piper Sandler 2 of 5 stars	Billy Fitzsimmons Not Rated	Lower Target	Overweight	$250.00 ➝ $215.00	+24.45%
3/10/2026	Northland Securities 5 of 5 stars	Nehal Chokshi 2 of 5 stars	Lower Target	Market Perform	$267.00 ➝ $229.00	+15.24%
3/2/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$197.00 ➝ $200.00	+3.94%
2/27/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$235.00 ➝ $200.00	+3.06%
2/26/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$280.00	+40.45%
2/26/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
2/26/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $250.00	+30.08%
2/26/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$281.00	+46.21%
2/26/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+108.13%

2/26/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$365.00 ➝ $320.00	+60.50%
2/26/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$280.00 ➝ $265.00	+33.78%
2/26/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$325.00 ➝ $250.00	+26.21%
2/26/2026	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Baldry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$395.00 ➝ $325.00	+64.78%
2/26/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Underperform	$223.00 ➝ $194.00	-1.42%
2/26/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$235.00 ➝ $210.00	+7.10%
2/26/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Perform	$290.00 ➝ $210.00	+5.38%
2/26/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$265.00 ➝ $252.00	+28.78%
2/26/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$300.00 ➝ $250.00	+27.84%
2/26/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$235.00 ➝ $225.00	+17.07%
2/24/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$400.00 ➝ $300.00	+60.45%
2/24/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$375.00	+110.68%
2/23/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$398.00 ➝ $287.00	+55.05%
2/23/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$375.00 ➝ $250.00	+35.06%
2/17/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$260.00 ➝ $200.00	+8.12%
1/15/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
12/29/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)
12/11/2025	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
12/4/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$340.00 ➝ $360.00	+49.91%
12/4/2025	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kirk Materne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$360.00 ➝ $340.00	+42.58%
12/4/2025	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Koenig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$250.00 ➝ $265.00	+6.51%
12/4/2025	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$300.00	+23.97%
12/4/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$325.00 ➝ $315.00	+32.09%
12/4/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
12/2/2025	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$430.00	+84.78%
11/17/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$325.00 ➝ $305.00	+25.07%
6/5/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/30/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$311.00 ➝ $309.00	+16.88%
5/28/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$320.00	+15.55%
3/17/2025	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Outperform	$400.00 ➝ $345.00	+23.43%

2/27/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$330.00 ➝ $300.00	+0.80%
2/19/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omar Sheikh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy
10/17/2024	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$343.00	+16.88%
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shebly Seyrafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stefan Slowinski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Strong-Buy	$325.00 ➝ $350.00	+35.19%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:23 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 4, 2026. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

The current stock price is around $183.98, which may present a buying opportunity for investors looking for growth in the cloud-based software sector.
Salesforce, Inc. reported a significant earnings per share of $3.81, exceeding analyst expectations, indicating strong financial performance and potential for future growth.
The company has shown a year-over-year revenue increase of 12.1%, reflecting its ability to grow and adapt in a competitive market.
Salesforce, Inc. has a robust market capitalization of approximately $150.54 billion, suggesting stability and investor confidence in its long-term prospects.
Analysts have a consensus rating of "Moderate Buy" with an average price target of $279.18, indicating positive sentiment and potential for stock appreciation.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

Recent organizational restructuring and workforce reductions may pose risks to short-term execution and employee morale, potentially impacting performance.
Salesforce's Slack unit is involved in legal action against Microsoft, which introduces uncertainty regarding future revenue and operational focus.
There has been recent short-term volatility in the stock, with a decline of approximately 2.6% in a prior session, raising concerns about market sentiment.
Some analysts have downgraded their target prices, indicating a cautious outlook on the stock's near-term performance.
Despite strong earnings, the company faces challenges in maintaining growth amidst increasing competition in the cloud software market.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 39 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $279.18, with a high forecast of $430.00 and a low forecast of $194.00.
: 39 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There is currently 1 sell rating, 11 hold ratings, 26 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted upside of 49.25% based on their 12-month stock forecasts.
: Salesforce has been rated by research analysts at Barclays, BMO Capital Markets, BTIG Research, Cantor Fitzgerald, Citigroup, DA Davidson, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer, Piper Sandler, Roth Mkm, Royal Bank Of Canada, Sanford C. Bernstein, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating for Salesforce is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

This page (NYSE:CRM) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CRM Analyst Ratings Over Time

CRM Analyst Recommendations By Month

CRM Price Targets by Month

Salesforce Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

Salesforce
Bull Case

Salesforce
Bear Case

CRM Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Salesforce (CRM) Stock Forecast & Price Target

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CRM Analyst Ratings Over Time

CRM Analyst Recommendations By Month

CRM Price Targets by Month

Salesforce Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

Salesforce Bull Case

Salesforce Bear Case

CRM Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Salesforce
Bull Case

Salesforce
Bear Case